APM

Aptorum Group Ltd Class A is an innovative biotechnology company headquartered in London, specializing in the discovery, development, and commercialization of advanced therapeutic solutions aimed at addressing critical health challenges such as infectious diseases and cancer. The company has developed a strong pipeline of proprietary drug candidates, supported by state-of-the-art research and technology, highlighting its dedication to filling significant unmet medical needs. With a strategic focus on expediting the transition of novel therapies to market, Aptorum Group is poised to significantly impact the pharmaceutical landscape and improve health outcomes for patients globally.